Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | MLYCD | O95822 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | SELE | P16581 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
| ▸ | CLK1 | P49759 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.31 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3450620 | 0.81 | CYP11B1 (0.36) | MAPK1CYP11B1CYP11B2MLYCDICAM1 | |
| SCHEMBL18137641 | 0.71 | TBXAS1 (0.44) | CYP11B2 | |
| SCHEMBL24966165 | 0.70 | MAPK1 (0.70) | MAPK1CYP11B1CYP11B2GPBAR1 | |
| SCHEMBL23234282 | 0.70 | MAPK1 (0.70) | MAPK1CYP11B1CYP11B2GPBAR1 | |
| SCHEMBL18137637 | 0.69 | SLC6A3 (0.36) | MAPK1CYP11B1CYP11B2MLYCD | |
| SCHEMBL18137612 | 0.69 | IDO1 (0.40) | ICAM1SELE | |
| SCHEMBL16462029 | 0.68 | HSD11B1 (0.35) | MLYCDICAM1SELETRPM8CLK1 | |
| SCHEMBL2507311 | 0.67 | HCAR2 (0.46) | MLYCDICAM1SELETRPM8CLK1 | |
| SCHEMBL20305483 | 0.65 | ESR1 (0.44) | MLYCDICAM1SELETRPM8CLK1 | |
| SCHEMBL14937988 | 0.64 | HTT (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2814814-B1 | IMIDAZOLYLKETONE DERIVATIVES ASD ALDOSTERONE SYNTHASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2019-05-08 | — | — | EP | disclosed |